Research Funding Update

The Myrovlytis Trust is delighted to award a grant extension to Dr Richard Harbottle at Imperial College London, UK. The six month extension will support ongoing work into the development of prophylactic gene therapy for BHD Syndrome using non-viral S-MAR plasmid vectors.